NIH Grant Scoring Scale: 1-9 Ratings, 10-90 Impact Scores

None of these numbers is a funding cutoff: NIH stopped using paylines from the January 2026 council round, and institutes weigh the review with mission and budget.

According to NIH's first-level peer-review guidance (opens in a new tab), the percentile, when provided, compares the application with the same scientific review committee's current and preceding two review rounds, so the same impact score can sit at different percentiles in different committees.

Current temporary rule: NIH's September 8, 2026 notice (opens in a new tab) keeps modified review through the January 2027 Advisory Council round. Most meetings discuss and score 30 to 35 percent of applications instead of the usual ~50 percent. The middle third is labeled competitive but not discussed, gets no overall impact score, and is still considered for funding. The bottom third is not competitive and not discussed.

Proposed change, not current policy: An August 14, 2026 NIH request for information (opens in a new tab) proposes reporting "most competitive" (top 25% of scores), "competitive" (26 to 50%), or "not discussed" instead of releasing final overall impact scores and percentiles. Comments were due October 13, 2026, and that comment period has closed. NIH says the request is for planning, not policy, so read the result in your eRA Commons record as it is today.

Use the NIH grants hub for current NIH routes, NIH study sections explained for review-group selection, and how to resubmit an NIH grant after you have the summary statement.

What NIH Pages Don't Tell You in One Place

Official NIH pages are the controlling sources, but the applicant answer is split across scoring, simplified review, temporary review, after-review, and funding-decision pages. The public pages do not combine a score calculation, percentile check, 2026 nondiscussion rule, posting timeline, and score-to-action screen.

That gap matters in search. The strongest public answer is therefore not another universal funding table. It is a source-checked distinction between what the number proves and what still requires institute context.

For example, one investigator at a university who receives a score of 40 with no percentile should record the arithmetic fact, a mean panel rating of 4.0, then read the summary and ask the program official about current institute context. Converting that 40 into an unofficial percentile or funding probability would add certainty that NIH did not provide.

Next route: Start with the result you actually received.

NIH Scoring System at a Glance

For most research project grant applications submitted for due dates on or after January 25, 2025, NIH uses its simplified review framework. The framework reorganized the former five scored criteria into three factors.

NIH can use different review criteria or nonnumeric scoring for some mechanisms. Always check the funding notice and review criteria for the exact application.

What Is the Range for Significance? Low and High R01 Scores

On an R01, significance is scored on NIH's 1 to 9 scale, but it no longer gets a score of its own. NIH's simplified review framework (opens in a new tab), for due dates on or after January 25, 2025, combines significance and innovation into Factor 1, Importance of the Research, "scored 1-9." Factor 2, Rigor and Feasibility, gets a second 1 to 9 score, and Factor 3 gets no number.

The scale runs backward from what most people expect: 1 is the best score and 9 is the worst. NIH's scoring descriptors (opens in a new tab) and its January 2026 reviewer guide (opens in a new tab) group the nine values into three bands:

So a "low" significance score in the everyday sense, a 2 for example, is a strong result, and a "high" number such as 7 is a weak one. NIH's reviewer guide anchors the middle: "1= exceptional; 5= average; 9= poor."

The Factor 1 score matters beyond its own line. NIH's scoring guidance (opens in a new tab) tells reviewers that "Your Factor 1 score should set a limit for the best possible overall impact score." A Factor 1 of 4 means that reviewer shouldn't give the application an overall rating better than 4, however strong the approach. That's why a weak significance case drags the whole application down, and why a summary statement full of Factor 2 fixes can still come back with a mediocre overall score.

Two cautions. Factor scores are individual reviewers' numbers and aren't averaged into the final 10 to 90 score. And career development (K) awards, fellowships and some other mechanisms use their own review criteria, which can still carry separate scores; check the review criteria in your funding notice.

How NIH Calculates the 10-90 Impact Score

Three or more assigned reviewers usually prepare the detailed critiques and preliminary assessments. That does not mean NIH simply averages three assigned reviewers to produce the final score.

After a discussed application is presented to the study section, all eligible panel members provide a final overall impact rating. According to NIH, the arithmetic mean of those eligible ratings is multiplied by 10 and reported as a whole-number final score.

For example:

1. Eligible panel members cast overall ratings.
2. Those ratings average 2.6.
3. NIH multiplies 2.6 by 10.
4. The final overall impact score is 26.

The overall impact rating is also not a mechanical average of Factor 1 and Factor 2. Reviewers consider all three factors and the application as a whole when assigning it.

NIH impact score conversion table

This table shows only the score arithmetic. It does not estimate a percentile or funding probability.

An impact score of 27, for example, reflects a mean eligible-panel rating of 2.7. It does not tell you the percentile without NIH's review-group calculation.

What an NIH Impact Score of 40 Means

Searchers often want one direct answer: an NIH impact score of 40 means the eligible panel ratings averaged 4.0.

It does not establish any of the following:

• 40th percentile
• 40 percent chance of funding
• a score inside or outside a universal NIH payline
• the same competitiveness across institutes, activity codes, or review groups

NIH's simplified scoring guidance describes ratings 1 to 3 as high, 4 to 6 as medium, and 7 to 9 as low. That guidance helps reviewers calibrate individual ratings. It is not a funding table. A final score of 40 still needs to be read with any percentile, the critique pattern, the assigned institute or center, and current funding decisions.

Impact Score vs. Priority Score vs. Percentile

Impact score and priority score

NIH materials commonly use overall impact score for the final 10 to 90 result. Applicants and older materials may also call it a priority score. When both labels refer to the final discussed-application score, they describe the same 10 to 90 result.

Do not confuse that final score with an individual reviewer's 1 to 9 rating or with the numeric scores shown for review factors.

Percentile

When NIH calculates a percentile, it compares the application's final impact score with scores from the same scientific review committee in:

• the current review round
• the preceding review round
• the review round before that

A 12th percentile result means the application scored as well as or better than approximately 88 percent of the comparison group. Lower percentile numbers are better.

The same raw impact score can produce different percentiles in different committees because scoring distributions differ. According to NIH, the percentile comparison uses the current and preceding 2 review rounds. Some applications do not receive a percentile. Do not convert an impact score with an unofficial online table or borrow the percentile from a different study section.

The 2026-27 Competitive-but-Not-Discussed Rule

NIH's September 8 continuation notice (opens in a new tab) extends temporary peer-review modifications through the January 2027 Advisory Council round. According to NIH, about 30 to 35 percent of applications are discussed under this process:

1. About 30 to 35 percent of applications are discussed and receive an overall impact score.
2. The middle third is designated competitive but not discussed.
3. The bottom third is designated not competitive and not discussed.

Applications in either nondiscussed group receive no overall impact score. NIH states that the competitive-but-not-discussed group may still be considered for funding. That makes older advice saying every nondiscussed application is automatically out of funding consideration incorrect for the temporary 2026 period.

The temporary summary statement format also differs. Applicants receive critiques and a concise consensus record, but not every element of the traditional discussed-application summary.

If your application is competitive but not discussed:

• read every critique when the summary statement arrives
• identify whether the concern is about Importance, Rigor and Feasibility, or Expertise and Resources
• contact the assigned program official for institute-specific context
• do not invent a score or percentile for the application
• keep both funding and revision paths open until you have current program guidance

Do not confuse the temporary rule with NIH's reporting proposal

NIH's August 2026 request for information (opens in a new tab) asks whether future review outcomes should be reported as most competitive, competitive, or not discussed. Under that proposal, NIH would still calculate a final overall impact score for discussed applications, but would not release that score or a percentile to applicants or NIH decision-makers. Written critiques and review-factor scores would remain available. NIH requested comments by October 13, 2026, and explicitly says the request is for planning, not policy.

The temporary January 2027 Council-round procedure is active; the three-category reporting model is a separate proposal. Don't use the proposal to translate a posted score into a new category. You can't infer a final rule from a request for information, and a comment deadline won't make that request effective policy. If NIH issues a final implementation notice, check the applicable review round and applicant instructions before changing this decision table.

How the Simplified Review Factors Affect the Score

Factor 1: Importance of the Research

Factor 1 combines significance and innovation. NIH's scoring guidance states that Factor 1 sets the ceiling for the best possible overall impact rating. In plain terms, exceptional execution cannot fully rescue a project the panel finds unimportant.

When Factor 1 drives the result, revision questions include:

• Is the problem important to the field and the funding institute?
• Is the knowledge gap specific and supported?
• Would the proposed result change scientific understanding or practice?
• Does the application explain what is new without relying on novelty alone?

Factor 2: Rigor and Feasibility

Factor 2 covers the approach. Reviewers examine design, methods, analysis, rigor, feasibility, and handling of biological variables where applicable.

When Factor 2 drives the result, sort critiques into concrete work:

• missing preliminary support
• weak controls or comparison groups
• unclear outcome measures
• underdeveloped statistical analysis
• recruitment or retention assumptions
• missing risk and alternative-strategy planning

Factor 3: Expertise and Resources

Factor 3 is rated as sufficient or as having identified gaps. It covers the investigator team and environment. A gap can worsen the overall impact rating even though Factor 3 has no separate 1 to 9 score.

Possible responses include adding missing expertise, clarifying collaborator roles, documenting access to required facilities, or showing that the team has completed comparable work.

What NIH Scores Get Funded?

There is no NIH-wide impact-score threshold that guarantees funding.

NIH's current funding-decision page describes a unified agency-wide approach. Institutes and centers no longer use fixed impact-score cutoff points as the sole funding rule. Funding decisions can consider:

• the complete peer-review record, including scores and critiques
• the institute or center's mission
• scientific topic and portfolio coverage
• career stage and workforce considerations
• broad geographic and institutional distribution
• available funds

Institute and center directors make final funding decisions. Council review is another part of the process, and funding can take months after peer review.

This does not make the impact score unimportant. It means the score is one strong signal inside a larger decision. A historical payline, an online forum post, or another investigator's score cannot prove what will happen to a current application.

Use NIH paylines explained for the distinction between historical paylines, published operating policies, and the current unified approach.

When NIH Scores and Summary Statements Are Posted

NIH's normal after-review timing is:

If the score is not posted after three business days, confirm that the meeting occurred, check the application record, and use eRA support or the assigned contacts shown in the record. Weekends and federal holidays are not business days.

According to NIH, the normal targets are 3 business days for the overall impact score and about 30 days for the summary statement. Applicants view both in eRA Commons (opens in a new tab).

How to Read the Summary Statement

Read the document as a decision record, not as a list of sentences to rebut.

1. Start with the consensus

For a discussed application, identify the central strengths and weaknesses reflected in the panel discussion. Those points are more useful than counting positive and negative adjectives.

Under the temporary 2026 process, a nondiscussed application receives a shorter consensus record plus critiques. Use the group designation and critique themes together.

2. Map each weakness to a review factor

Create three columns:

3. Separate repairable issues from premise problems

A missing analysis detail can be repairable. A panel that doubts the central premise may require new evidence or a different project, not a point-by-point edit.

4. Check administrative concerns

Human subjects, inclusion, vertebrate animals, biohazards, authentication, budget, and other administrative notes can require action even when they did not drive the scientific score.

5. Speak with the program official

After the summary statement arrives, ask focused questions:

• Which critique themes appear most important for a future submission?
• Is the application still receiving current funding consideration?
• Does the project fit the institute's present scientific priorities?
• Would a revised submission, new application, or different notice be the better route?

The program official cannot promise funding or rewrite the application, but can provide context that a generic score chart cannot.

Score-to-Action Decision Screen

The decision is not "Is 30 good?" The useful question is: What did the panel conclude, how does NIH compare this application, and which next action can change the evidence?

Bad-fit checks before resubmitting

A resubmission is a bad fit when the available action cannot answer the review record. Stop before drafting if the central premise lacks support, the proposed work no longer fits the funding notice, the required expertise cannot be added, or the applicant would need to hide an unchanged weakness behind new wording. In those cases, a new project, mechanism, notice, or evidence-building step is the better route.

Common NIH Score Interpretation Errors

Treating score 40 as the 40th percentile. The final impact score and percentile are different measures.

Averaging the assigned reviewers only. The final score uses ratings from all eligible panel members after discussion.

Averaging review factors to predict the final score. Overall impact is a separate judgment informed by all factors.

Using a universal funding table. NIH does not publish one impact-score-to-funding conversion.

Calling every nondiscussed result a rejection. The temporary 2026 process permits funding consideration for competitive-but-not-discussed applications.

Comparing scores across unrelated study sections. Percentiles exist partly because raw scoring distributions differ.

Revising before reading the summary statement. The score alone cannot identify what must change.

Related NIH Guides

• NIH Paylines Explained
• NIH Study Sections Explained
• How to Resubmit an NIH Grant
• How to Respond to Grant Reviewer Comments
• How to Read Your NIH Summary Statement
• NIH Grants Complete Guide

Sources

• NIH, First Level of Review (opens in a new tab)
• NIH, Simplified Review Framework (opens in a new tab)
• NIH, Reviewer Guidance (opens in a new tab)
• NIH, Scoring System and Procedure (1 to 9 descriptors) (opens in a new tab), accessed October 1, 2026
• NIH, Simplified Review: Reviewer Guide to Evaluating Applications (opens in a new tab), accessed October 1, 2026
• NIH, Simplified Review Scoring Guidance (opens in a new tab)
• NIH, Temporary modifications to peer review, NOT-OD-26-069 (opens in a new tab)
• NIH, Continuation through the January 2027 Advisory Council, NOT-OD-26-114 (opens in a new tab)
• NIH, Request for information on proposed changes to reporting peer-review outcomes, NOT-OD-26-088 (opens in a new tab)
• NIH, Competitive but not discussed explanation (opens in a new tab)
• NIH, After Review (opens in a new tab)
• NIH eRA, eRA Commons help (opens in a new tab)
• NIH, Funding Decisions (opens in a new tab)